𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

✍ Scribed by Maemondo, Makoto; Inoue, Akira; Kobayashi, Kunihiko; Sugawara, Shunichi; Oizumi, Satoshi; Isobe, Hiroshi; Gemma, Akihiko; Harada, Masao; Yoshizawa, Hirohisa; Kinoshita, Ichiro; Fujita, Yuka; Okinaga, Shoji; Hirano, Haruto; Yoshimori, Kozo; Harada, Toshiyuki; Ogura, Takashi; Ando, Masahiro; Miyazawa, Hitoshi; Tanaka, Tomoaki; Saijo, Yasuo; Hagiwara, Koichi; Morita, Satoshi; Nukiwa, Toshihiro

Book ID
118038176
Publisher
Massachusetts Medical Society
Year
2010
Tongue
English
Weight
341 KB
Volume
362
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib or Chemotherapy for Non–Small-
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
✍ Maemondo, Makoto; Inoue, Akira; Kobayashi, Kunihiko; Sugawara, Shunichi; Oizumi, 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 341 KB

## Background: Non-small-cell lung cancer with sensitive mutations of the epidermal growth factor receptor (egfr) is highly responsive to egfr tyrosine kinase inhibitors such as gefitinib, but little is known about how its efficacy and safety profile compares with that of standard chemotherapy. ##